サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1726193

コンパニオンアニマル用ワクチンの市場規模、シェア、動向分析レポート：動物タイプ別、製品別、投与経路別、流通チャネル別、製品別、地域別、セグメント予測、2025年～2030年

Companion Animal Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Product, By Route Of Administration, By Distribution Channel, By Product, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
コンパニオンアニマル用ワクチンの市場規模、シェア、動向分析レポート：動物タイプ別、製品別、投与経路別、流通チャネル別、製品別、地域別、セグメント予測、2025年～2030年
出版日: 2025年04月09日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンパニオンアニマル用ワクチン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、コンパニオンアニマル用ワクチンの世界市場規模は2030年までに62億7,000万米ドルに達し、予測期間中にCAGR 8.25％で成長すると予測されています。

ペット飼育の動向の高まりに加え、ペットが最愛の家族として扱われる人間化が進んでいることが、市場成長の原動力となっています。2023～2024 APPA National Pet Owners Surveyによると、米国世帯の66％、約8,690万世帯がペットを飼っています。ペットが不可欠な家族の一員とみなされるにつれ、飼い主は予防接種や獣医療を通じてペットの健康に投資する傾向が強まり、中核ワクチンと非中核ワクチンの両方の需要を押し上げています。ペットの人間化はまた、ワクチン接種スケジュールを遵守することの重要性を認識し、愛犬が適時に必要不可欠な予防接種を受けられるようにする、より知識豊富な飼い主をもたらします。

ペット保険会社は、より広範な獣医療サービスを含むよう補償範囲を拡大することで、コンパニオンアニマル・ワクチン市場の成長を促す貴重な機会を得ています。ウェルネスケア、定期予防接種、歯科治療、行動療法、鍼治療、レーザー治療、カイロプラクティック治療などの代替療法を保険プランに組み込むことで、ペット保険会社は、動物にホリスティックで予防的な医療を優先させる飼い主の増加傾向にアピールすることができます。

より包括的な保険へのシフトは、ペットの飼い主が定期的に動物病院を受診することを促し、定期的なケアの一環として、コア・ワクチンと非コア・ワクチンの両方が接種されることが多いです。その結果、コンパニオンアニマル・ワクチンの需要が増加します。例えば、メットライフ生命ペット保険は、ワクチン接種やその他の代替治療が獣医師によって実施され、保険の対象となる場合に限り、保険契約者に払い戻しを行うことで、すでにこの傾向をサポートしています。このような保険は、予防接種を含む早期介入と予防医療を促進し、最終的にはこのようなサービスをより身近で手頃なものにすることで、ワクチンセグメントの成長を促進します。

市場参入企業は、研究開発への投資、製品ポートフォリオの拡大、戦略的パートナーシップの形成、新たな地域への市場参入などにより、コンパニオンアニマル用ワクチン市場の成長促進に重要な役割を果たしています。このような努力は、ペットの飼育や動物の健康に対する意識が世界的に高まる中、効果的で革新的なワクチンに対する需要の高まりに応えるのに役立っています。例えば、Merckアニマルヘルス（MSD）は2024年、RNA粒子技術を用いた初の犬用インフルエンザワクチンであるNOBIVAC（R）NXT Canine Flu H3N2の米国農務省の承認を取得しました。これは、アジュバントを使用しない少量投与で免疫反応を高めるという、技術的に重要なマイルストーンです。

コンパニオンアニマル用ワクチン市場レポートハイライト

  • 2024年には、犬の人口増加と世界の犬飼育率の上昇により、イヌのセグメントが最大の収益シェアを占め、市場を独占しました。
  • 2024年、弱毒生ワクチン市場は37.00%以上のシェアでコンパニオンアニマル用ワクチン市場を独占したが、予測期間中、組み換えワクチン市場は最も速いCAGRで成長すると予測されます。
  • 皮下投与セグメントは、その適用しやすさと副作用リスクの低減により、2024年に41.0%以上の最大売上シェアで市場を独占しました。
  • 2024年のコンパニオンアニマル用ワクチン市場では、病院/クリニック薬局が最大の売上シェアを占めました。
  • 北米地域は、2024年に28%以上の最大の収益シェアを占めました。同地域はペット飼育の増加により力強い成長を遂げています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コンパニオンアニマル用ワクチン市場の変動動向と展望

  • 市場系統の展望
    • 親市場
    • 補助市場
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • コンパニオンアニマル用ワクチン市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
    • 規制の枠組み
    • 価格分析
    • 疾患有病率分析
    • 主要国別、主要種による動物推定個体数（2024年）
    • 製品パイプライン分析

第4章 コンパニオンアニマル用ワクチン市場：動物タイプ別、推定・動向分析

  • セグメントダッシュボード
  • コンパニオンアニマル用ワクチン市場：動物タイプ変動分析
  • コンパニオンアニマル用ワクチン市場規模と動向分析（動物タイプ別、2018～2030年）
  • イヌ
  • ネコ
  • その他

第5章 コンパニオンアニマル用ワクチン市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • コンパニオンアニマル用ワクチン市場：製品変動分析
  • コンパニオンアニマル用ワクチン市場規模と動向分析（製品別、2018～2030年）
    • 弱毒生ワクチン
    • 不活化ワクチン
    • サブユニットワクチン
    • DNAワクチン
    • 組み換えワクチン

第6章 コンパニオンアニマル用ワクチン市場：投与経路別、推定・動向分析

  • セグメントダッシュボード
  • コンパニオンアニマル用ワクチン市場：投与経路変動分析
  • コンパニオンアニマル用ワクチン市場規模と動向分析（投与経路別、2018～2030年）
    • 皮下
    • 筋肉内
    • 鼻腔内

第7章 コンパニオンアニマル用ワクチン市場：流通チャネル別、推定・動向分析

  • セグメントダッシュボード
  • コンパニオンアニマル用ワクチン市場：流通チャネル変動分析
  • コンパニオンアニマル用ワクチン市場規模と動向分析（流通チャネル別、2018～2030年）
    • 小売
    • eコマース
    • 病院/クリニック薬局

第8章 コンパニオンアニマル用ワクチン市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • コンパニオンアニマル用ワクチン市場シェア（地域別、2024年と2030年）、単位：100万米ドル
  • 地域展望
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 市場参入企業の分類
  • 企業の市況分析/ヒープマップ分析
  • 企業プロファイル
    • Merck & Co., Inc.
    • Zoetis
    • Virbac
    • Elanco
    • Boehringer Ingelheim Animal Health
    • Phibro Animal Health Corporation
    • Calier
    • Ceva
    • Bimeda Biologicals
    • Neogen Corporation
  • 戦略マッピング
    • 合併と買収
    • パートナーシップとコラボレーション
    • 拡大
    • 製品発売
    • 製品承認
    • その他
  • その他の主要参入企業一覧
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Companion Animal Vaccines Market, by region, 2018 - 2030 (USD Million)
  • Table 3 Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 4 Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 5 Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 7 North America Companion Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 9 North America Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 10 North America Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 12 U.S. Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 16 Canada Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 17 Canada Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 18 Canada Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Mexico Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 21 Mexico Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 22 Mexico Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Europe Companion Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 26 Europe Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 27 Europe Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Germany Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 30 Germany Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 31 Germany Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 33 UK Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 34 UK Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 35 UK Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 UK Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 37 France Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 38 France Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 39 France Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 France Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 41 Italy Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 42 Italy Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 43 Italy Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Spain Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 46 Spain Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 47 Spain Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Denmark Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 50 Denmark Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 51 Denmark Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Denmark Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Sweden Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 54 Sweden Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 55 Sweden Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 57 Norway Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 58 Norway Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 59 Norway Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Norway Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Companion Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 66 China Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 67 China Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 68 China Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 China Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 70 Japan Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 71 Japan Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 72 Japan Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Japan Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 74 India Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 75 India Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 76 India Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 India Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 78 South Korea Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 79 South Korea Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 80 South Korea Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 South Korea Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 82 Australia Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 83 Australia Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 84 Australia Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Australia Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 86 Thailand Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 87 Thailand Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 88 Thailand Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Thailand Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 90 Latin America Companion Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 92 Latin America Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 93 Latin America Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 95 Brazil Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 96 Brazil Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 97 Brazil Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 99 Argentina Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 101 Argentina Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 103 MEA Companion Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 105 MEA Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 106 MEA Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 MEA Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 108 South Africa Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 110 South Africa Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 116 UAE Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 117 UAE Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 118 UAE Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Companion Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Companion Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Companion Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Companion Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
  • Table 124 Company Overview
  • Table 125 Product Benchmarking
  • Table 126 Financial Performance
  • Table 127 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Companion Animal Vaccines Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Companion Animal Vaccines Market snapshot
  • Fig. 11 Companion Animal Vaccines Market driver impact
  • Fig. 12 Companion Animal Vaccines Market restraint impact
  • Fig. 13 Companion Animal Vaccines animal type key takeaways (USD Million)
  • Fig. 14 Companion Animal Vaccines Market: animal Type movement analysis
  • Fig. 15 canine market, 2018 - 2030 (USD Million)
  • Fig. 16 Feline market, 2018 - 2030 (USD Million)
  • Fig. 17 Others market, 2018 - 2030 (USD Million)
  • Fig. 18 Companion Animal Vaccines Market Product key takeaways (USD Million)
  • Fig. 19 Companion Animal Vaccines Market: product movement analysis
  • Fig. 20 Attenuated live vaccines market, 2018 - 2030 (USD Million)
  • Fig. 21 Inactivated vaccines market, 2018 - 2030 (USD Million)
  • Fig. 22 Subunit Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 23 DNA vaccines market, 2018 - 2030 (USD Million)
  • Fig. 24 Recombinant Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 25 Companion Animal Vaccines Market route of administration key takeaways (USD Million)
  • Fig. 26 Companion Animal Vaccines Market: route of administration movement analysis
  • Fig. 27 Subcutaneous vaccines market, 2018 - 2030 (USD Million)
  • Fig. 28 Intramuscular vaccines market, 2018 - 2030 (USD Million)
  • Fig. 29 Intranasal Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 30 Companion Animal Vaccines Market by distribution channel key takeaways (USD Million)
  • Fig. 31 Companion Animal Vaccines Market: by distribution channel movement analysis
  • Fig. 32 hospitals/clinic pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 33 Retail pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 34 E-Commerce market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional market place: Key takeaways
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 North America Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 44 France Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain Companion Animal Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 52 China Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 53 India Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 60 MEA Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait Companion Animal Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 65 Market participant categorization
目次
Product Code: GVR-4-68040-550-6

Companion Animal Vaccines Market Growth & Trends:

The global companion animal vaccines market size is expected to reach USD 6.27 billion by 2030, growing at a CAGR of 8.25% during the forecast period, according to a new report by Grand View Research, Inc. The growing trend of pet ownership, along with the increasing humanization of pets where they are treated as beloved family members continues to fuel market growth. According to the 2023-2024 APPA National Pet Owners Survey, 66% of U.S. households, or approximately 86.9 million, own a pet. As pets are seen as integral family members, owners are more inclined to invest in their health through vaccinations and veterinary care, boosting demand for both core and non-core vaccines. Pet humanization also results in more knowledgeable pet owners who recognize the importance of adhering to vaccination schedules, ensuring their dogs receive timely and essential immunizations.

Pet insurance companies have a valuable opportunity to stimulate growth in the companion animal vaccines market by expanding their coverage to include a wider range of veterinary services. By incorporating wellness care, routine vaccinations, dental treatments, behavioral therapy, and alternative therapies such as acupuncture, laser therapy, and chiropractic care into their insurance plans, these companies can appeal to a growing segment of pet owners who prioritize holistic and preventative healthcare for their animals.

This shift toward more comprehensive coverage encourages pet owners to engage more frequently in regular veterinary visits, where vaccines both core and non-core are often administered as part of routine care. As a result, demand for companion animal vaccines increases. For instance, MetLife Pet Insurance already supports this trend by reimbursing policyholders for vaccinations, and other alternative treatments, provided they are veterinarian-administered and covered under the policy. This type of coverage promotes early intervention and preventive healthcare, which includes vaccinations, ultimately driving growth in the vaccine segment by making such services more accessible and affordable.

Market players play a critical role in driving the growth of the companion animal vaccines market by investing in research and development, expanding product portfolios, forming strategic partnerships, and entering new geographic markets. These efforts help meet the rising demand for effective and innovative vaccines as pet ownership and awareness about animal health increase globally. For instance, Merck Animal Health (MSD), in 2024, received USDA approval for NOBIVAC(R) NXT Canine Flu H3N2, the first canine influenza vaccine using RNA-particle technology. This is a major technological milestone, providing enhanced immune response with low-volume, adjuvant-free doses.

Companion Animal Vaccines Market Report Highlights:

  • In 2024, the canine segment dominated the market with the largest revenue share, owing to the increased dog population and rising dog ownership globally.
  • The attenuated live vaccines segment dominated the companion animal vaccines market with a share of over 37.00% in 2024, whereas the recombinant vaccine segment is anticipated to grow at the fastest CAGR over the forecast period.
  • The subcutaneous segment dominated the market with a largest revenue share of over 41.0% in 2024, due to its ease of application and reduced risk of adverse reactions.
  • Hospital/clinic pharmacy held the largest revenue share of the companion animal vaccines market in 2024
  • The North American region accounted for a largest revenue share of over 28% in 2024. The region is experiencing strong growth due to rising pet ownership

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Animal Vaccines Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising pet population
      • 3.2.1.2. Increasing disease outbreak
      • 3.2.1.3. Rising R&D and manufacturing advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of awareness
      • 3.2.2.2. Complex regulations
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Companion Animal Vaccines Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Disease Prevalence Analysis
    • 3.3.6. Estimated Animal Population by key countries, key species, 2024
    • 3.3.7. Product Pipeline Analysis

Chapter 4. Companion Animal Vaccines Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion Animal Vaccines Market: Animal type Movement Analysis
  • 4.3. Companion Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Companion Animal Vaccines Market: By Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion Animal Vaccines Market: By Product Movement Analysis
  • 5.3. Companion Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
    • 5.3.1. Attenuated Live Vaccines
      • 5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Inactivated Vaccines
      • 5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Subunit Vaccines
      • 5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. DNA Vaccines
      • 5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Recombinant Vaccines
      • 5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Companion Animal Vaccines Market: By Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion Animal Vaccines Market: By Route of Administration Movement Analysis
  • 6.3. Companion Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
    • 6.3.1. Subcutaneous
      • 6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Intramuscular
      • 6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Intranasal
      • 6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Companion Animal Vaccines Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion Animal Vaccines Market: By Distribution Channel Movement Analysis
  • 7.3. Companion Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
    • 7.3.1. Retail
      • 7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. E-Commerce
      • 7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Hospital/Clinic Pharmacy
      • 7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Companion Animal Vaccines Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Companion Animal Vaccines Market Share, By Region, 2024 & 2030, USD Million
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. U.S. Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Canada Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Mexico Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. UK Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Germany Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. France Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Italy Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Spain Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Denmark Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Sweden Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Norway Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Japan Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. China Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. India Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Australia Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. South Korea Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Thailand Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Brazil Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Argentina Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. South Africa Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Saudi Arabia Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. UAE Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Kuwait Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Merck & Co., Inc.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Virbac
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Elanco
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Boehringer Ingelheim Animal Health
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Phibro Animal Health Corporation
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Calier
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Ceva
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Bimeda Biologicals
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Neogen Corporation
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Expansion
    • 9.4.4. Product launch
    • 9.4.5. Product Approval
    • 9.4.6. Others
  • 9.5. List of other key players